Improved Long-term Survival after Liver Resection for Hepatocellular Carcinoma in the Modern Era: Retrospective Study from HCV-endemic Areas (original ) (raw )Predictors of Recurrence in Hepatitis C Virus Related Hepatocellular Carcinoma after Hepatic Resection: A Retrospective Cohort Study
Ahmed Shehta
The Eurasian Journal of Medicine, 2014
View PDFchevron_right
Second Hepatic Resection for Recurrent Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Shigekazu Takemura
World Journal of Surgery, 2008
View PDFchevron_right
The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
Ching-Hui Chuang
Medicina, 2022
View PDFchevron_right
The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients
Shinn-cherng Chen , Wan-long Chuang
Journal of Gastroenterology and Hepatology, 2015
View PDFchevron_right
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort
Odile Goria
Clinics and Research in Hepatology and Gastroenterology, 2020
View PDFchevron_right
Risk of Recurrence in a Long-term Follow-up After Surgery in 417 Patients With Hepatitis B- or Hepatitis C-Related Hepatocellular Carcinoma
Terumasa Yamada
Annals of Surgery, 2006
View PDFchevron_right
Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C Virus
Kiyoshi Hasegawa
Journal of Clinical Oncology, 2013
View PDFchevron_right
Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma
Hisashi Nakayama
BMC Gastroenterology, 2019
View PDFchevron_right
Hepatitis C and hepatocellular carcinoma
Francis Yao
Current Treatment Options in Oncology, 2001
View PDFchevron_right
Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy
Akihiro Tamori
American Surgeon, 2017
View PDFchevron_right
Hepatitis C Virus Infection is a Risk Factor for Tumor Recurrence after Resection of Small Hepatocellular Carcinomas
Cheng-yuan Hsia , Jaw-ching Wu
World Journal of Surgery, 2004
View PDFchevron_right
The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment
Shinya Maekawa
Internal Medicine
View PDFchevron_right
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area
Ting-Tsung Chang
Liver International, 2005
View PDFchevron_right
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C
Francisco Durazo , Mitsugi Shimoda
Liver Transplantation, 2004
View PDFchevron_right
Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review
Mohamed El-Kassas
Journal of Advanced Research, 2019
View PDFchevron_right
Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct‐acting antivirals
Akihiro Tamori
Journal of Surgical Oncology, 2020
View PDFchevron_right
Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma
Akihiro Tamori
Hepatology Research, 2002
View PDFchevron_right
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
Daniele Nicolini
Digestive and Liver Disease
View PDFchevron_right
Recurrent Hepatocellular Carcinoma in Liver Transplant Recipients with Hepatitis C
Ivan Zendejas
Journal of Gastrointestinal Cancer, 2010
View PDFchevron_right
Hepatitis C virus and hepatocellular carcinoma
Raffaella Romeo
Best Practice & Research Clinical Gastroenterology, 1999
View PDFchevron_right
Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment
Kazuhiro Nouso , Hepatoma Research
Hepatoma Research, 2019
View PDFchevron_right
Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals
xavier adhoute
European Journal of Gastroenterology & Hepatology, 2018
View PDFchevron_right
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
Fulvio Calise
Hepatology, 2006
View PDFchevron_right
Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2
Takashi Kumada
Journal of Medical Virology, 2001
View PDFchevron_right
Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C
Hepatoma Research
Hepatoma Research, 2022
View PDFchevron_right
De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus
Mohamed Nabil
European journal of gastroenterology & hepatology, 2017
View PDFchevron_right
Frequency of De Novo Hepatocellular Carcinoma after Direct-acting Antiviral Therapy for Chronic Hepatitis C: A Prospective Follow-up
Aneeqa Ahmad
Euroasian Journal of Hepato-Gastroenterology
View PDFchevron_right
Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region
Milotka Fabri
Journal of Gastroenterology, 2013
View PDFchevron_right
Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis
Rui Marinho
Digestive Diseases and Sciences, 2011
View PDFchevron_right
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
Joseph koffi DOKPO
Liver international : official journal of the International Association for the Study of the Liver, 2017
View PDFchevron_right
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication
Akihiro Tamori
Clinical Infectious Diseases, 2019
View PDFchevron_right
Management of hepatitis C infection (regional guideline)
Kamran Lankarani
Hepat Mon, 2004
View PDFchevron_right